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1) Hamazaki k吋 SawazakiS., Itomura M吋 Huan M円 ShibaharaN吋 KawakitaT刊 KobayashiS円
and Hamazaki T.: No effect of a traditional Chinese medicine, Hochu-ekki-to, on antibody 
titer after influenza vaccination in man: a randomized, placebo・ ontrolled, double皿blind
trial. Phytomedicine 14: 11-14, 2007. 
Abstract: BACKGROUND: It was shown that a traditional Chinese medicineラHochu-ekki-to(HET), had 
adjuvant effects in influenza vaccination in an animal experiment. Thisラhowever.ラcouldnot be assessed in 
a clinical study. METHODS: Thirty-two healthy subjects were randomly assigned to two groups (control 
and HET groups) in a double-blind manner. HET subjects (n=17) took 7.5 g ofHET/day for two weeks; 
control subjects took the same amount of indistinguishable placebo. Then subjects were vaccinated 
against influenza (HINI, H3N2 and B/Shandong). Hemagglutinin titers and natural killer (NK) activity 
were measured at weeks Oラ1,2ヲ4ラand12. RESULTS: Antiinfluenza titers against the three viruses were 
increased continuously for the first two weeks and leveled o任 However,there were no significant 
differences in any titers between the two groups. NK activity peaked at week 2 without any inter-group 
differences. CONCLUSION: We could not find any adjuvant effects of HET ir this experimental 
condition. 
2) Hussein G, Nakagawa T吋 GotoH吋 ShimadaY円 MatsumotoK., Sankawa U円 andWatanabe 
H.: Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr可 p.Life Sci円
80:522・529,2007. 
Abstract: Glucose and lipid metabolic parameters play crucial roles in metabolic syndrome and its major 
feature of insulin resistance. This study was designed to investigate whether dietary astaxanthin oil 
(ASX-0) has potential effects on metabolic syndrome features in an SHR/NDmcr目cp( cp/cp) rat model. 
Oral administration of ASX (50 mg/kg/day) for 22 weeks induced a significant reduction in arterial blood 
pressure in SHRcp. It also significantly reduced the fasting blood glucose level, homeostasis index of 
insulin resistance (HOMA-IR), and improved insulin sensitivity. The results also showed an improved 
adiponectin level, a significant increase in high-density lipoprotein cholesterol, a significant decrease in 
plasma levels of triglycerides, and non-esterified fatty acids. Additionally, ASX showed significant effects 
on the white adipose tissue by decreasing the size of the fat cels. These results suggest that ASX 
ameliorates insulin resistance by mechanisms involving the increase of glucose uptake, and by modulating 
the level of circulating lipid metabolites and adiponectin. 
3) Nakagawa T., Goto H刊 HikiamiH吋 YokozawaT吋 ShibaharaN吋 andShimada Y.: Protective 
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effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats. J 
Ethnopharmacol吋 110:311・317,2007. 
Abstract: Keishibukuryogan, one of the traditional herbal formulations, is used clinically to improve 
blood circulation. It consists of the following five crude drugs: Cinnamomi Cortex, Poria, Moutan Cortex, 
Persicae Semen and Paeoniae Radix. In this study, the effects ofkeishibukuryogan against renal damage in 
spontaneously diabetic WBN/Kob rats were examined. Oral administration of keishibukuryogan 
significantly attenuated urinary protein excretion and serum creatinine levels. It did not affect body weight 
loss and blood glucose levels, but it suppressed renal and hepatic weights of WBN/Kob rats. 
Keishibukuryogan also reduced fibronectin and transforming growth factor ~（ 1) (TGF－~(l)) protein 
expression in the renal cortex. Furthermore, lipid peroxidation levels in both kidney and liver were 
significantly lower than those of untreated control WBN/Kob rats. Urinary excretion of 
8-hydroxy-deoxyguanosine was suppressed by keishibukuryogan treatment. These results suggest that 
keishibukuryogan reduces oxidative stress by hyperglycemiaラ andthat it protects renal function and 
suppresses fibronectin deposition induced by TGF－~(l) production in WBN/Kob rats. 
4) Terashima Y.吋 Hamazakik吋 ItomuraM円 HuanM刊 ShibaharaN吋 KobayashiS., and 
Hamazaki T.: Effect of a traditional Chinese medicine, maobushisaishinto, on the antibody 
titer after influenza vaccination: A randomized, placebo圃controlled,double-blind trial. J. 
Trad. Med円 24:59-66, 2007. 
Abstract: Background: It was shown that a traditional Chinese medicine, maobushisaishinto (MBST), 
had adjuvant effects on influenza vaccination in an animal experiment and an open trial in elderly subjects. 
Purpose: To examine the adjuvant effects of MBST in a closer clinical experiment. Methods: Forty-seven 
healthy subjects between 20 and 71 y of age were randomly assigned to two groups (control and MBST 
groups) in a double-blind manner. The subjects in the MBST group (n=23) took l.68g spray-dried powder 
of MBST/day for two weeks; the rest (control subjectsラn=24)took the same amount of indistinguishable 
placebo. Then subjects were vaccinated against influenza viruses (A/HINI, A/H3N2 and B). Serum 
hemagglutination inhibition titers were measured at weeks Oラ1ラ2ラ4,and 12. Results: The titers against the 
three viruses were increased continuously for the first two weeks and leveled o任 HoweverラMBSTwas 
not superior to placebo in any titers. Conclusion: We could not find any adjuvant effects of MBST in this 
experimental condition. 
5) Nozaki k叫 GotoH刊 NakagawaT., Hikiami H円 Koizumik円 ShibaharaN刊 andShimada Y.: 
Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats. Biol 
Pharm Bull. 30: 1042・1047,2007. 
Abstract: It is known that rheumatoid arthritis (RA) accelerates atherosclerosis. Further, the soluble form 
of vascular adhesion molecule-1 (VCAM-1) is known as a predictive marker of atherosclerosis in RA 
patients. We reported that keishibukuryogan, one of the Kampo formulasラimprovedarticular symptoms 
and decreased soluble VCAM-1 in patients with RA. In adjuvant-induced arthritis (AIA) rats, an animal 
model of RA, it is known that endothelial function is injured by inflammation. So, we investigated the 
effect of keishibukuryogan on endothelial function in AIA rats. Lewis rats were divided into control, AIA 
controlラ andAIA with keishibukuryogan groups. The AIA with keishibukuryogan group was fed 3% 
keishibukuryogan contained in normal chow. On day 25 after injection of Mycobacterium butyricum, 
endothelium-dependent relaxation by acetylcholine in the AIA control group was suppressed, but it was 
improved in the AIA with keishibukuryogan group. The contractions by xanthine/xanthine oxidase in both 
AIA rats increased, but that in keishibukuryogan decreased compared to the AIA control group. Plasma 
levels of lipid peroxide increased in the AIA control group, but keishibukuryogan decreased these levels. 
Plasma levels of nitric oxide (NO) increased in both AIA groups. The expressions of endothelial NO 
synthase, inducible NO synthase and VCAM-1 of thoracic aorta were investigated by western blotting. 
These expressions increased in the AIA control group, but were restricted in the AIA with 
keishibukuryogan group. We considered that keishibukuryogan protected the endothelial function of AIA 
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rats mainly by its anti-oxidative effect. 
く〉総説
1) 柴原直利：｛貧血病態の理解と最新の治療】 漢方療法 貧血の漢方治療．カレントテラ
ピー， 25:219
く〉症例報告 Case reports 
1) 関矢信康ラ林克美ラ地野充時ラ笠原裕司ラ並木隆雄，巽武司ラ小暮敏明ラ柴原直利ラ平崎能郎，
寺津捷年：半夏厚朴湯の使用目標の検討肩甲間部痛・違和感について．日本東洋医学










1) Nozaki kラHikiamiH, Goto H, Nakagawa TラShibaharaNラShimadaY: Keishibukuryogan 
(Gui之hi-Fu・Ling-Wan),a Kampo Formula, Decreases Disease Activity and Soluble Vascular 
Adhesion Molecule-I in Patients with Rheumatoid Arthritis. Innovative Team Program in Peking 
University • 21st Cen印ryCOE Program in University of Toyama Joint Symposium, 2007, 6ラ
Beijing. 
2) Nozaki K, Goto H, Nakagawa T, Hikiami H, Koizumi K, Shibahara N, Shimada Y: Effects of 
Keishibukuryogan on Vascular Function in Adjuvant-Induced Arthritis Rats. Innovative Team 
Program in Peking University • 21st Century COE Program in University of Toyama Joint 
Symposiumラ2007,6, Beijing. 
3) Shibahara NラGotoHラNakagawaTラHikiamiHラYanagaA, Shimada Y: Cinnamaldehyde Induces 
Endothelium-dependent and -independent Vasorelaxant Action on Isolated Rat Aorta. Innovative 
Team Program in Peking University ・21stCentury COE Program in University of Toyama Joint 
Symposium, 2007, 6ラBeijing.
4) Shibahara N., Goto H.ラNakagawaT., Hikiami H.ラYanagaA.ラShimadaY.: Cinnamaldehyde 
Induces Endothelium-dependent and -independent Vasorelaxant Action on Isolated Rat Aorta. The 
14th International Congress of Oriental Medicinι2007. 12. Taipei, Taiwan. 
5) Goto H.ラShimadaY.ラHikiamiA., Mitsuma T., Shintani T., Ninomiya H., NiizawaA.ラNagasakaK.ラ
Shibahara N., Terasawa K.: Effect of Keishibukuryogan on Silent Brain Infarction over 3 years. 
The 14th International Congress of Oriental Medicineラ2007.12. TaipeiラTaiwan.
6) JoM.ラNakamuraN., Kakiuchi N.ラKomatsuK.ラQuiM.H.ラShimotohnoK.ラShimotohnoK., Hattori 
M., Goto H.ラHikiamiA.ラShimadaY.ラNakagawaT., Sakai S.ラShibaharaN.: Inhibitory effect of 
Yunnan traditional medicines on hepatitis C viral polymerase. The 14th International Congress of 
Oriental Medicine, 2007. 12. TaipeiラTaiwan.
7) Nozai K.ラGotoH.ラNakagawaT.ラHikiamiH.ラKoizumiK., Shibahara N., Shimada Y.: Effects of 
Keishibukuryogan on vascular function in a司juvant-inducedarthritis rats. The 14th International 






























































例．第 33回日本東洋医学会北陸支部例会， 2007, 10，富山．
29) 村井政史，野崎和也，海老津茂，原田智子，永田豊，井上博喜，小尾龍右，引網宏彰，
酒井伸也，後藤博三，柴原直手lj，嶋田豊：漢方治療により健康食品から離脱しえたアト
ピー性皮膚炎の一例．第 33回日本東洋医学会北陸支部例会， 2007, 10，富山．
30) 柴原直利，酒井伸也，中川孝子，条美智子，引網宏彰，後藤博三，楼井宏明，済木育夫，
嶋田豊：生活習慣病に対する漢方薬の効果解析に基づく個の医療の創生一生活習慣病に
おける桂枝夜苓丸の効果 ．富山大学 21世紀 COEプログラム「東洋の知に立脚した個

















2) 柴原直利：症例検討．第7回富山漢方談話会， 2007, 1，富山．
3) 柴原直利：補剤による漢方治療．北大阪臨床漢方セミナー I, 2007, 1，大阪
4) 柴原直利：漢方医学概論 陰陽虚実・気血水 ，漢方医学教育の実際と漢方医学のエビ
デンス，呼吸器疾患の漢方治療，漢方診療の実際．大学勤務医のための漢方医学セミ
ナー ， 2007, 1，東京．






8) 柴原直利：症例検討．第 8回富山漢方談話会， 2007, 3，富山．






12) 柴原直手IJ：補中益気湯証について．第5回OSAKi生漢方研究会， 2007, 7，大阪．












19) 柴原直手IJ：症例検討．第 1回富山漢方談話会， 2007, 9，富山．
20) 柴原直手IJ：腸疾患の漢方治療．第25回湯本求異学術講演会， 2007, 9，金沢．
21) 柴原直手lj：最近の漢方処方のあれこれ柴胡剤と駆疹血剤の使い方－，附子剤の使い方，
症例検討．大阪漢方 StepUpセミナー ， 2007, 1，大阪．













漢方薬の効果解析に基づく個の医療の創生」， 2005, 10～ 
済木育夫：富山大学和漢医薬学総合研究所病態生化学分野教授，「生活習慣病に対する漢

















1) 柴原直利：富山大学薬学部，「東洋医学概論J,2007, 1～2 
2) 藤本孝子：富山福祉短期大学介護福祉専攻，「家政学実習IJ, 2007, 4～7 
3) 藤本孝子：富山福祉短期大学児童福祉専攻，「小児栄養J,2007ラ4～7
4) 藤本孝子：富山福祉短期大学介護福祉専攻，「家政学概論 IJ, 2007,4～7 
5) 柴原直利：富山大学，「和漢医薬学入門」， 2007ラ5,1. 













2.外国人客員研究員：張詰（中医師，中国， 2007, 4.5～12.31) 
3.長期研修生
1) 木村真梨（大学院医学薬学研究部（医学）博士課程，富山県， 2007, 1.1～12.31) 
1) 飯田ゆかり（大学院医学薬学研究部（薬学）修士課程臨床薬学，富山県， 2007,1.9～3.16) 
2) 尾山由貴江（大学院医学薬学研究部（薬学）修士課程臨床薬学，富山県， 2007,1.9～3.16) 
3) 鈴木望美（大学院医学薬学研究部（薬学）修士課程臨床薬学，富山県， 2007, 1.9～3.16) 
4) 鈴木寿樹（大学院医学薬学研究部臨床薬学修士課程，富山県， 2007, 1.9～3.16) 
5) 原田智子（医師，富山県， 2007,4.1～12.31) 
6) 海老津茂（医師，富山県， 2007,4.1～12.31) 
7) 荻野恵里奈（医師，大阪府， 2007, 8.1～12.31) 
8) 金子真利亜（大学院医学薬学研究部（薬学）博士課程，富山県， 2007, 10.1～12.31) 
4.短期研修生
1) 金子真利亜（薬剤師，新潟県， 2007, 1.15～1.26) 
2) 荻野恵里奈（医師，大阪府， 2007,2.1～2.2) 
3) 丸本万里子（薬剤師，大阪府， 2007,2.19～2.23) 
4) 根岸亜希子（医学生，富山県， 2007, 3.5～3.9) 
5) 古屋舞（医学生，愛知県， 2007, 3.5～3.9) 
6) 高橋美紗代（薬剤師，富山県， 2007,3.19～3.30) 
7) 大塚佳代（薬学生，大阪府， 2007, 5.14～5.15) 
8) 中道雅夫（薬学生，大阪府， 2007, 5.14～5.15) 
9) 川瀬雅也（薬剤師，大阪府， 2007, 5.14～5.15) 
10) 錦織理華（薬剤師，大阪府， 2007, 5.14～5.15) 
11) 姫野栄志（薬学生，京都府， 2007, 6.13～6.14) 
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12) 中塚友貴子（薬学生，広島県， 2007, 6.20～6.21) 
13) 山上実紀（医師，北海道， 2007, 8.6～8.10) 
14) 貴島篤彦（薬学生，東京者~＇ 2007, 8.6～8.17) 
15) 井原稔文（医学生，高知県， 2007, 8.6～8.10) 
16) 三浦純江（医学生，山梨県， 2007, 9.10～9.14) 
17) 小林一乃（薬剤師，愛知県， 2007, 9.25～10.5) 
18) 関隆志（医師，宮城県， 2007, 10.25～10.26) 
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